ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994

NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain

March 5, 1993

Program Announcement listed.

July 25, 2003

Colorectal Cancer Screening Programs Could Cut Future Treatment Costs

September 25, 2009

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

Smaller Ultrasound-Guided Biopsy Needle Safe, Effective, For Suspected Breast Cancer

May 30, 2003